Switch to Gliflozins and Biventricular Function Improvement in Patients with Chronic Heart Failure and Diabetes Mellitus.

Michele CorrealePietro MazzeoMartino FortunatoMatteo ParadisoAndrea FuroreAngela Ilaria FanizziLucia TricaricoGiuseppe PastoreSimona AlfieriNatale Daniele BrunettiOlga Lamacchia

Published in: Clinical physiology and functional imaging (2023)

In a real-world scenario, treatment with SGLT2i in patients with CHF and diabetes is associated with an improvement in both left and right ventricular function assessed at echocardiography. These data may explain potential anti-remodelling effects of gliflozins. This article is protected by copyright. All rights reserved.

Keyphrases

type diabetes
glycemic control
cardiovascular disease
left ventricular
computed tomography
pulmonary hypertension
electronic health record
heart failure
big data
ejection fraction
metabolic syndrome
skeletal muscle
cardiac resynchronization therapy
climate change
deep learning
insulin resistance